Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Mentari Therapeutics, Inc. is a clinical-stage biotechnology company developing therapies for the prevention of migraine. The Company's lead programs are MT-001, an anti-PACAP monoclonal antibody, and MT-002, an anti-pituitary adenylate cyclase-activating polypeptide (PACAP) and anti-calcitonin gene-related peptide (CGRP) bispecific antibody with the potential to deliver efficacy for people with incomplete response to existing therapies. It is advancing a robust portfolio of potentially therapies that target validated pathways in migraine biology. MT-001 and MT-002, both target pituitary adenylate cyclase-activating polypeptide, an emerging and clinically validated target. MT-001, an investigational monoclonal antibody with potential for efficacy and convenient, infrequent subcutaneous dosing. MT-002 is an investigational bispecific antibody targeting both PACAP and CGRP that is designed for infrequent subcutaneous dosing.
Find out what a historical investment in Mentari Therapeutics Inc would be worth today using our MTRI stock calculator.
Buying MTRI shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Mentari Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in MTRI
What is the ticker symbol of Mentari Therapeutics Inc?
The ticker symbol for Mentari Therapeutics Inc is MTRI.
How much is one share of MTRI?
One share of MTRI is valued at $15.25 as of 20 November 2026.
What is the market capitalisation of Mentari Therapeutics Inc MTRI?
As of 20 November 2026 Mentari Therapeutics Inc has a market cap of $807.26M.
What is the 52-week high for Mentari Therapeutics Inc stock?
The Mentari Therapeutics Inc 52-week high stock price is $23.30.
What is the 52-week low for Mentari Therapeutics Inc stock?
The Mentari Therapeutics Inc 52-week low stock price is $5.75.
Can I buy MTRI shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy MTRI shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in MTRI on Stake
Buy MTRI from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of MTRI from only US$10 with fractional shares